Propiedad y actividad de insiders de Adaptimmune Therapeutics plc (ADAP): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.05 |
| Capitalización | $75M |
| Bolsa | NASDAQ |
| País | GB |
Balance (10 años)
| Año | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $229.1M | $158.8M | $84.0M | $68.4M | $50.4M | $56.9M | $149.9M | $108.0M | $144.0M | $91.1M |
| Inversiones a Corto | $55.3M | $22.7M | $124.2M | $136.8M | $39.1M | $311.3M | $219.6M | $96.6M | $2.9M | $60.5M |
| Cuentas por Cobrar | $5.4M | $7.7M | $11.7M | $16.7M | $19.3M | $20.7M | $34.0M | $38.1M | $46.9M | $16.0M |
| Inventario | $102212 | $1.2M | $3.8M | $1.1M | $1.5M | 0 | 0 | 0 | 0 | $7.3M |
| Activos Corrientes | $295.1M | $198.8M | $230.2M | $231.1M | $120.5M | $398.2M | $415.5M | $255.4M | $207.6M | $188.2M |
| Inmovilizado Material | $5.4M | $27.9M | $40.7M | $36.1M | $51.9M | $46.7M | $51.4M | $71.5M | $71.7M | $51.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $177692 | $1.3M | $1.3M | $1.5M | $2.2M | $1.7M | $1.0M | $442000 | $330000 | $3.9M |
| Activos Totales | $300.7M | $234.5M | $281.1M | $276.7M | $181.5M | $451.1M | $469.5M | $328.9M | $282.6M | $246.0M |
| Cuentas por Pagar | $7.8M | $11.3M | $8.4M | $4.1M | $6.4M | $6.4M | $8.1M | $4.8M | $8.1M | $8.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $26.8M | $40.3M | $74.3M | $24.4M | $34.3M | $39.1M | $62.5M | $64.5M | $72.8M | $64.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $50.2M |
| Pasivos Totales | $41.1M | $68.4M | $78.2M | $29.9M | $57.9M | $109.9M | $263.6M | $247.0M | $243.1M | $234.1M |
| Reservas | -$47.2M | -$161.5M | -$231.6M | -$318.5M | -$455.7M | -$585.8M | -$743.8M | -$909.3M | -$1.02B | -$1.09B |
| Patrimonio Neto | $259.6M | $166.1M | $203.0M | $246.9M | $123.6M | $341.2M | $206.0M | $81.9M | $39.5M | $11.8M |
| Deuda Total | 0 | 0 | $124.2M | $136.8M | $25.5M | $23.7M | $25.5M | $23.1M | $25.2M | $74.2M |
| Deuda Neta | -$284.4M | -$181.5M | -$84.0M | -$68.4M | -$64.1M | -$344.5M | -$344.1M | -$181.5M | -$121.7M | -$77.4M |
| Capital Circulante | $268.3M | $158.5M | $155.9M | $206.7M | $86.1M | $359.1M | $352.9M | $190.9M | $134.8M | $123.6M |
Salud financiera
| Deuda / Patrimonio | -0.69 |
| Ratio corriente | 1.52 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -5.47 |
Rentabilidad
| Rentabilidad sobre capital | 143.79% |
| Rentabilidad sobre capital invertido | -90.90% |
| Rentabilidad sobre activos | -59.65% |
| Margen bruto | 83.88% |
| Margen operativo | -362.66% |
| Margen neto | -371.74% |
Empresas relacionadas: ANL · APLM · BLRX · ERNA · GOVX · LNAI · LPCN
Explorar sector: Healthcare · Biotechnology
Más secciones de ADAP: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones